TD Cowen lowered the firm’s price target on Procter & Gamble to $175 from $189 and keeps a Buy rating on the shares. The firm noted they reported a slight Q3 sales miss and lowered sales and EPS guidance for FY25 to reflect weaker consumer confidence particularly in U.S., and 3-5c of tariff costs in 4Q.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PG:
- Procter & Gamble price target lowered to $175 from $185 at Wells Fargo
- Procter & Gamble: Long-Term Growth Potential Amid Short-Term Challenges Justifies Buy Rating
- Procter & Gamble price target lowered to $181 from $200 at Citi
- Procter & Gamble price target lowered to $180 from $190 at BofA
- Procter & Gamble upgraded to Outperform from Sector Perform at RBC Capital
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue